Netscientific PLC (LON:NSCI)‘s stock had its “buy” rating reaffirmed by investment analysts at Stifel Nicolaus in a research report issued on Friday. They presently have a GBX 160 ($2.00) target price on the stock. Stifel Nicolaus’ price target would indicate a potential upside of 144.27% from the company’s current price.

Shares of Netscientific PLC (LON:NSCI) opened at 65.50 on Friday. Netscientific PLC has a 52-week low of GBX 60.00 and a 52-week high of GBX 114.80. The company’s market cap is GBX 33.45 million. The firm has a 50-day moving average of GBX 67.36 and a 200-day moving average of GBX 73.95.

About Netscientific PLC

NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics.

Receive News & Stock Ratings for Netscientific PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Netscientific PLC and related stocks with our FREE daily email newsletter.